Business
Press Release Jan 25 2023
Cipla Limited has informed the Exchange regarding a press release dated January 25, 2023, titled "Q3FY23 results".
About this update from Cipla Ltd
Cipla Limited has informed the Exchange regarding a press release dated January 25, 2023, titled "Q3FY23 results". View Attachment
More from Cipla Ltd
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda in the US
September 4, 2026
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in...
September 3, 2026